The Role of Central Neurotensin in Regulating Feeding and Body Weight
The small peptide neurotensin (Nts) is implicated in myriad processes including analgesia, thermoregulation, reward, arousal, blood pressure, and modulation of feeding and body weight. Alterations in Nts have recently been described in individuals with obesity or eating disorders, suggesting that disrupted Nts signaling may contribute to body weight disturbance. Curiously, Nts mediates seemingly opposing regulation of body weight via different tissues. Peripherally acting Nts promotes fat absorption and weight gain, whereas central Nts signaling suppresses feeding and weight gain. Thus, because Nts is pleiotropic, a location-based approach must be used to understand its contributions to disordered body weight and whether the Nts system might be leveraged to improve metabolic health. Here we review the role of Nts signaling in the brain to understand the sites, receptors, and mechanisms by which Nts can promote behaviors that modify body weight. New techniques permitting site-specific modulation of Nts and Nts receptor–expressing cells suggest that, even in the brain, not all Nts circuitry exerts the same function. Intriguingly, there may be dedicated brain regions and circuits via which Nts specifically suppresses feeding behavior and weight gain vs other Nts-attributed physiology. Defining the central mechanisms by which Nts signaling modifies body weight may suggest strategies to correct disrupted energy balance, as needed to address overweight, obesity, and eating disorders.
Top-30
Journals
|
1
2
3
|
|
|
International Journal of Molecular Sciences
3 publications, 6.67%
|
|
|
Addiction Neuroscience
2 publications, 4.44%
|
|
|
eLife
2 publications, 4.44%
|
|
|
Frontiers in Neural Circuits
1 publication, 2.22%
|
|
|
BMC Endocrine Disorders
1 publication, 2.22%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 2.22%
|
|
|
Neurochemical Research
1 publication, 2.22%
|
|
|
Journal of Internal Medicine
1 publication, 2.22%
|
|
|
Nature
1 publication, 2.22%
|
|
|
Theriogenology
1 publication, 2.22%
|
|
|
Cell Metabolism
1 publication, 2.22%
|
|
|
Neuropsychopharmacology
1 publication, 2.22%
|
|
|
Atherosclerosis
1 publication, 2.22%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 2.22%
|
|
|
bioRxiv
1 publication, 2.22%
|
|
|
Current Neuropharmacology
1 publication, 2.22%
|
|
|
Journal of the American Chemical Society
1 publication, 2.22%
|
|
|
Journal of Clinical Endocrinology and Metabolism
1 publication, 2.22%
|
|
|
Marine Drugs
1 publication, 2.22%
|
|
|
Obesity
1 publication, 2.22%
|
|
|
Vitamins and Hormones
1 publication, 2.22%
|
|
|
Cortex
1 publication, 2.22%
|
|
|
JCI insight
1 publication, 2.22%
|
|
|
Obesity Pillars
1 publication, 2.22%
|
|
|
Hikaku seiri seikagaku(Comparative Physiology and Biochemistry)
1 publication, 2.22%
|
|
|
Neurogastroenterology and Motility
1 publication, 2.22%
|
|
|
Journal of Neuroscience
1 publication, 2.22%
|
|
|
Cell Research
1 publication, 2.22%
|
|
|
Brain Sciences
1 publication, 2.22%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
|
|
|
Elsevier
11 publications, 24.44%
|
|
|
Cold Spring Harbor Laboratory
8 publications, 17.78%
|
|
|
Springer Nature
7 publications, 15.56%
|
|
|
MDPI
5 publications, 11.11%
|
|
|
Frontiers Media S.A.
3 publications, 6.67%
|
|
|
Wiley
3 publications, 6.67%
|
|
|
eLife Sciences Publications
2 publications, 4.44%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 2.22%
|
|
|
American Chemical Society (ACS)
1 publication, 2.22%
|
|
|
The Endocrine Society
1 publication, 2.22%
|
|
|
American Society for Clinical Investigation
1 publication, 2.22%
|
|
|
The Japanese Society for Comparative Physiology and Biochemistry
1 publication, 2.22%
|
|
|
Society for Neuroscience
1 publication, 2.22%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.